本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Olema Pharmaceuticals, Inc.

4.64
-0.0800-1.69%
盘后4.640.00000.00%17:49 EDT
成交量:51.52万
成交额:239.84万
市值:3.17亿
市盈率:-2.38
高:4.83
开:4.74
低:4.57
收:4.72
52周最高:13.93
52周最低:2.86
股本:6,842.13万
流通股本:4,310.84万
量比:0.90
换手率:1.20%
股息:- -
股息率:- -
每股收益(TTM):-1.9468
每股收益(LYR):-2.2041
净资产收益率:-41.59%
总资产收益率:-27.44%
市净率:0.83
市盈率(LYR):-2.11

数据加载中...

2024/06/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/06

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/06/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/15

重要事件披露

Form 8-K - Current report
2024/05/08

重要事件披露

Form 8-K - Current report
2024/05/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/22

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/03/11

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/11

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/11

重要事件披露

Form 8-K - Current report
2024/03/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/15

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]